Prognosis
AstraZeneca’s Vaccines Go Unused in EU as Mutants Spread
- Some health workers cite concerns about side effects of shots
- EU’s vaccination program lags far behind U.K. and U.S.
This article is for subscribers only.
Just weeks ago, the European Union was clamoring for AstraZeneca Plc’s Covid-19 vaccine. Now, fewer than one-tenth of the doses delivered to Germany have been administered in the initial days of the roll-out, and some health-care workers say they’re concerned about side effects.
Germany isn’t alone: Some French health workers are also pushing to get shots from Moderna Inc., Pfizer Inc. and BioNTech SE instead. Their reluctance comes after a clash last month over whether EU countries would get their fair share of AstraZeneca’s shipments as deliveries slowed.